Sequenom (NASDAQ: SQNM) and Vascular Solutions (NASDAQ:VASC) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, earnings, profitabiliy, institutional ownership and analyst recommendations.


This table compares Sequenom and Vascular Solutions’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Sequenom -21.54% N/A -25.05%
Vascular Solutions 13.02% 15.78% 14.30%

Institutional and Insider Ownership

46.0% of Sequenom shares are owned by institutional investors. Comparatively, 80.2% of Vascular Solutions shares are owned by institutional investors. 3.1% of Sequenom shares are owned by company insiders. Comparatively, 6.9% of Vascular Solutions shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Sequenom and Vascular Solutions’ top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Sequenom N/A N/A N/A ($0.34) -7.03
Vascular Solutions N/A N/A N/A $0.70 80.00

Sequenom is trading at a lower price-to-earnings ratio than Vascular Solutions, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings for Sequenom and Vascular Solutions, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sequenom 0 1 0 0 2.00
Vascular Solutions 0 4 0 0 2.00

Sequenom presently has a consensus target price of $0.75, suggesting a potential downside of 68.62%. Vascular Solutions has a consensus target price of $53.33, suggesting a potential downside of 4.76%. Given Vascular Solutions’ higher possible upside, analysts plainly believe Vascular Solutions is more favorable than Sequenom.

Risk & Volatility

Sequenom has a beta of 1.17, meaning that its stock price is 17% more volatile than the S&P 500. Comparatively, Vascular Solutions has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500.


Vascular Solutions beats Sequenom on 7 of the 8 factors compared between the two stocks.

About Sequenom

Sequenom, Inc. is a life sciences company. The Company serves patients and physicians by providing early patient management information. The Company operates through Sequenom Laboratories segment. It conducts its business as a molecular diagnostics clinical laboratory located in San Diego, California and Raleigh-Durham, North Carolina. Its testing focus is on prenatal health that includes molecular-based laboratory developed tests (LDTs). The Company’s diagnostic services are provided through its subsidiary, Sequenom Center for Molecular Medicine LLC (SCMM), doing business as Sequenom Laboratories. Sequenom Laboratories develops and validates its tests to be used as a testing service to physicians. Sequenom Laboratories is focused on developing and offering a menu of tests for prenatal continuum of care. The Sequenom Laboratories’ test offerings in the prenatal market include MaterniT21 PLUS LDT, HerediT CF test, SensiGene RhD test, VisibiliT test and Test Send-out Agreements.

About Vascular Solutions

Vascular Solutions, Inc. is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world. Its products include GuideLiner catheters, Pronto catheters, Vein catheter reprocessing, Micro-introducer kits, Hemostatic patches, Radial access products, Langston catheters and D-Stat Flowable hemostat. The Company’s product portfolio includes a spectrum of over 90 products consisting of approximately 900 stock keeping units (SKUs) covering an array of blood clotting devices, extraction catheters, access catheters, guide extension catheters, micro-introducer kits, guidewires, snare and retrieval devices, a reprocessing service for radiofrequency catheters and a laser and procedure kits for the treatment of varicose veins.

Receive News & Ratings for Sequenom Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sequenom Inc. and related companies with's FREE daily email newsletter.